San Diego, CA, United States of America

Shahram Salek-Ardakani

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 2.2

ph-index = 7

Forward Citations = 178(Granted Patents)


Company Filing History:


Years Active: 2007-2018

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Shahram Salek-Ardakani: Advancements in Viral Vaccination and Treatment Methods

Introduction

Shahram Salek-Ardakani is an esteemed inventor based in San Diego, California, recognized for his impactful contributions to the field of immunology. With a remarkable portfolio of nine patents, he has made significant strides in the research and development of methods aimed at combating viral infections and improving vaccination techniques.

Latest Patents

Two of Shahram Salek-Ardakani's latest patents underscore his groundbreaking work in the area of viral vaccination and treatment methodologies. The first patent, titled "Virus vaccination and treatment methods with OX40 agonist compositions," introduces compositions that utilize OX40 (CD134), a TNF receptor superfamily protein, alongside viral antigens for effective treatment of viral infections and enhanced immunization strategies.

His second recent patent focuses on "Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same". This inventiveness is pivotal, as it addresses the persistence of T cell memory in the absence of antigens, emphasizing the importance of OX40 in maintaining the longevity of Th2 memory in allergic responses. Shahram's findings reveal that inhibiting OX40 during reactivation of memory cells can both reduce inflammation and impact the memory's longevity during subsequent encounters with allergens.

Career Highlights

Shahram currently operates out of the La Jolla Institute for Allergy and Immunology, a leading research facility where his innovative work has flourished. His research focuses on pivotal aspects of immune response and allergic conditions, making significant contributions to the understanding of immunological memory and treatment paradigms in allergic asthma.

Collaborations

Throughout his career, Shahram Salek-Ardakani has collaborated with notable colleagues, including Michael Croft and Taylor Doherty. These partnerships have further enriched his research contributions and led to an enhanced understanding of immune responses and therapeutic interventions.

Conclusion

In summary, Shahram Salek-Ardakani stands out as a pivotal figure in the landscape of immunology. His array of innovative patents and collaborative endeavors exemplifies a commitment to advancing the field of viral vaccination and treatment. As he continues his work at the La Jolla Institute for Allergy and Immunology, his contributions will undoubtedly shape the future of medical science in combating viral infections and enhancing immune responses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…